CARDIOMPO TEST— 510(k) K050029

Substantially Equivalent

Prognostix, Inc.

FDA 510(k) clearance K050029 for CARDIOMPO TEST, Substantially Equivalent on 2005-05-10. Applicant: Prognostix, Inc..

Clearance details

Applicant: Prognostix, Inc.
Product code: Code NTV
Advisory panel: Immunology
Date received: 2005-01-06
Decision date: 2005-05-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Cleveland, OH, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.